Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Gilead Sciences Inc (GILD)

NASDAQ
Currency in USD
Disclaimer
65.42
+0.15(+0.23%)
Closed
After Hours
65.50+0.08(+0.12%)

GILD Comments

No one sane will take this super rushed vaccine
is 5g chipping for GPS tracking
my friend, clearly you don't understand the difference. Gilead news is about remdesivir which is used to cure patients who is already covid-19 positive. A vaccine is like flu shots, injected to people in hope that they don't catch covid-19 (immune). And yes, vaccine is prob not widely accepted by general mass since the proven result is still limited.
yes
going to negative?
This stock is supposed to be up big time. Somethings not right
This stock is supposed to be up big time. Something is not right
just got in @62 believe will rise over the weekend i will hold my position but knowing that after earning if it doesn't come with a super news like a mejor contract for billions definitely will be out peace guys
Earnings come next week.. thats why the upside will be limited
true mainly with tech companies but Gild’s earnings are expected to disappoint
any link about it?
Gild’s earnings may disappoint but now they have IMMU which has turned around and will surprise
Slow start
This stock is a joke
Only 3.6% up?? Come on
i agree, this should be going to $65 atleast..
above 70 after earnings
https://www.cnbc.com/2020/10/08/eu-signs-joint-procurement-contract-for-remdesivir-supply.html
Meanwhile, covid new cases are increasing again and HIV treatments and other drugs Gilead have probably increased sales this last quarter
Let's see how the stock trades today...
Nothing new to dive on Gild
Interesting to see how this chart only surges every two years then drops like a rock
How high yiu think this will pop in the am
$69 i think, just guess
No one sane will take this super rushed vaccine. Dangerous
Guess if you want your job theyll say to take it
hopefullt tonight we will see 70
 If shorters got ribbed off their pants, it is possible due to a painful squeeze. There are about 20 Million shares out-balance for short (public info) anyway.
I mean tomorrow - it is possible going way over $70.
I hope you right, I just don't see it happening with only this FDA news about Redensivir. But with good earnings I believe it will go to 70's again (or maybe even higher)
Finally, this stock has done nothing but go down since I bought it at $80 months ago.
Shorters' accounts will ***up on coming days... agree?
Again, in O'Day we trust!!!
with this stock, wait with the parties .be careful
How long before pulling the trigger and buying this stock ?
Yes! is happening ..... where the bears at tho?... and where is W.H.O... lowkey they were getting some calls behind that report
Niceeeeeee!
Giys this was being used for people with covid before it got approved but now it has the fda backing
Your thoughts on proce tomoerow ?
I'm guessing 65's at least... This stock was trading lately on 52 week lows. It has a decent dividend and we are 5 days away from earnings. Next week maybe 68/70
if $75 sb will have to file bankruptcy...
I found this article for you: - https://www.investing.com/news/stock-market-news/gileads-covid19-drug-wins-full-fda-approval-2331190
digesting covid full FDA approval!?
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.